Cdk5 Inhibitory Peptide Prevents Loss of Neurons and Alleviates Behavioral Changes in p25 Transgenic Mice.

Journal of Alzheimer's Disease : JAD
Yaowei HuangYa-Fang Hu

Abstract

Accumulation of p25 is thought to be a causative risk factor for Alzheimer's disease (AD). As a cleaved product of p35, p25 binds to cyclin-dependent kinase 5 (Cdk5) and leads to the hyperactivity of Cdk5. Then, Cdk5/p25 phosphorylates many pathological substrates related to neurodegenerative diseases. p25 transgenic (Tg) mouse model recaptures some pathological changes of AD, including tau hyperphosphorylation, neurofibrillary tangles, neuroinflammation, and neuronal death, which can be prevented by transgenic expression of Cdk5 inhibitory peptide (CIP) before the insult of p25. In the present study, we would like to know whether adeno-associated virus serotype-9 (AAV9)-mediated CIP can protect neurons after insult of p25 in p25Tg mice. Administration of AAV9-CIP or control virus were delivered in the brain of p25Tg mice via intracerebroventricular infusions following the induction of p25. Western blotting, immunohistochemistry and immunofluorescence assessment, and animal behavioral evaluation were performed. Brain atrophy, neuronal death, tau phosphorylation and inflammation in the hippocampus, and cognitive decline were observed in p25Tg mice. Administration of CIP but not the control virus in p25Tg mice reduced levels of t...Continue Reading

References

Jul 21, 1999·Neuroscience Research·K Y LeeR N Johnston
Mar 8, 2000·Proceedings of the National Academy of Sciences of the United States of America·M K AhlijanianJ D McNeish
Jul 10, 2001·The Journal of Biological Chemistry·L LiljaC Bark
Oct 5, 2001·Nature Reviews. Molecular Cell Biology·R Dhavan, L H Tsai
Nov 14, 2002·Molecular Neurobiology·Toshio Ohshima, Katsuhiko Mikoshiba
Nov 26, 2002·Journal of Alzheimer's Disease : JAD·Carola OtthRicardo B Maccioni
May 11, 2005·Expert Opinion on Investigational Drugs·Peter M Fischer, Athos Gianella-Borradori
Sep 13, 2005·Nature Medicine·Fan-Yan WeiKazuhito Tomizawa
Jan 12, 2010·Cell Cycle·Vassiliki LaliotiIgnacio V Sandoval
Apr 9, 2011·Progress in Neurobiology·Joao P Lopes, Paula Agostinho
Jan 21, 2012·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Jeyapriya R SundaramSashi Kesavapany
Oct 6, 2012·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Varsha ShuklaHarish C Pant
Jan 4, 2013·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Jeyapriya Raja SundaramSashi Kesavapany
Oct 22, 2014·Proceedings of the National Academy of Sciences of the United States of America·Hei-Man ChowJie Zhang
Nov 12, 2015·International Journal of Molecular Sciences·Takashi AmemoriEva Sykova
Nov 29, 2015·Human Molecular Genetics·Katherine A High, Xavier M Anguela
Apr 20, 2017·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Yong HeYafang Hu
Nov 2, 2017·The New England Journal of Medicine·Jerry R MendellBrian K Kaspar
Dec 7, 2017·The New England Journal of Medicine·Lindsey A GeorgeKatherine A High
Jan 13, 2018·Science·Cynthia E DunbarMichel Sadelain
Sep 20, 2019·Molecular Therapy. Methods & Clinical Development·Shilpa PrabhakarXandra O Breakefield

❮ Previous
Next ❯

Citations

May 5, 2021·The International Journal of Neuroscience·Xiaobo ZhangWenpeng Peng
May 14, 2021·Journal of Drug Targeting·Qin OuyangQubo Zhu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Animal Models

Alzheimer's disease is a neurodegenerative disease which can be studied using various experimental systems. This feed focuses on animal models used for Alzheimer's disease research.

Attention Disorders

Attention is involved in all cognitive activities, and attention disorders are reported in patients with various neurological diseases. Here are the latest discoveries pertaining to attention disorders.

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.